Overview

Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see if Humira is effective and safe in the treatment of sarcoidosis.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest University
Treatments:
Adalimumab